Literature DB >> 17211458

Cellular mechanisms underlying the pharmacological induction of phosphenes.

L Cervetto1, G C Demontis, C Gargini.   

Abstract

Visual sensations evoked by stimuli other than luminance changes are called phosphenes. Phosphenes may be an early symptom in a variety of diseases of the retina or of the visual pathways, but healthy individuals may perceive them as well. Phosphene-like phenomena are perhaps the most common side effect reported in clinical pharmacology. Ivabradine, a novel anti-anginal drug that reduces heart-rate by inhibiting the hyperpolarization activated current expressed in cardiac sinoatrial node cells (I(f)) induces phosphenes in some patients. One hypothesis is that ivabradine interacts with the visual system by inhibiting hyperpolarization-activated current in retinal cells (Ih). An Ih current with properties similar to cardiac I(f) has been reported in retinal neurones. Under normal circumstances most of the random fluctuations generated within the retinal circuits do not reach the level of conscious perception because they are filtered out. Presumably, filtering occurs mostly within the retina and one serious candidate for this action is the ability of Ih to act as a negative-feedback mechanism. Ih activation in the membrane of visual cells causes dampening of responses to slow noisy inputs thus tuning the visual system to perceptually more relevant signals of higher frequency. Ih inhibition, by altering at the retinal synapses the filtering of signals generated by thermal breakdown of rhodopsin or other fluctuations, is expected to increase the probability of phosphene occurrence. It is the purpose of the present paper to outline and discuss the features of the visual system and the pharmacological conditions relevant to phosphene perception.

Entities:  

Mesh:

Year:  2007        PMID: 17211458      PMCID: PMC2189731          DOI: 10.1038/sj.bjp.0706998

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  98 in total

Review 1.  Will retinal implants restore vision?

Authors:  Eberhart Zrenner
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

2.  Hyperpolarisation rectification in cat lateral geniculate neurons modulated by intact corticothalamic projections.

Authors:  D A Nita; M Steriade; F Amzica
Journal:  J Physiol       Date:  2003-08-22       Impact factor: 5.182

3.  Inward rectifying currents stabilize the membrane potential in dendrites of mouse amacrine cells: patch-clamp recordings and single-cell RT-PCR.

Authors:  Amane Koizumi; Tatjana C Jakobs; Richard H Masland
Journal:  Mol Vis       Date:  2004-05-13       Impact factor: 2.367

4.  Objective assessment of cortical excitability in migraine with and without aura.

Authors:  E P Chronicle; A J Pearson; W M Mulleners
Journal:  Cephalalgia       Date:  2006-07       Impact factor: 6.292

Review 5.  Novel If current inhibitor ivabradine: safety considerations.

Authors:  Irina Savelieva; A John Camm
Journal:  Adv Cardiol       Date:  2006

6.  Artifical vision for the blind: electrical stimulation of visual cortex offers hope for a functional prosthesis.

Authors:  W H Dobelle; M G Mladejovsky; J P Girvin
Journal:  Science       Date:  1974-02-01       Impact factor: 47.728

7.  Alinidine modifies the pacemaker current in sheep Purkinje fibers.

Authors:  D J Snyders; P P Van Bogaert
Journal:  Pflugers Arch       Date:  1987-09       Impact factor: 3.657

8.  Use-dependent blockade of cardiac pacemaker current (If) by cilobradine and zatebradine.

Authors:  Pierre Paul Van Bogaert; François Pittoors
Journal:  Eur J Pharmacol       Date:  2003-10-08       Impact factor: 4.432

9.  Magnetic stimuli applied over motor and visual cortex: influence of coil position and field polarity on motor responses, phosphenes, and eye movements.

Authors:  B U Meyer; R Diehl; H Steinmetz; T C Britton; R Benecke
Journal:  Electroencephalogr Clin Neurophysiol Suppl       Date:  1991

Review 10.  Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.

Authors:  Dario DiFrancesco; John A Camm
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more
  16 in total

Review 1.  Exploring HCN channels as novel drug targets.

Authors:  Otilia Postea; Martin Biel
Journal:  Nat Rev Drug Discov       Date:  2011-11-18       Impact factor: 84.694

2.  Novel blockers of hyperpolarization-activated current with isoform selectivity in recombinant cells and native tissue.

Authors:  Martina Del Lungo; Michele Melchiorre; Luca Guandalini; Laura Sartiani; Alessandro Mugelli; Istvan Koncz; Tamas Szel; Andras Varro; Maria Novella Romanelli; Elisabetta Cerbai
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  Ivabradine: a new rate-limiting therapy for coronary artery disease and heart failure.

Authors:  Gordon F Rushworth; Philippe Lambrakis; Stephen J Leslie
Journal:  Ther Adv Drug Saf       Date:  2011-02

4.  Effect of ivabradine, a novel antianginal agent, on driving performance: A randomized, double-blind, placebo-controlled trial in healthy volunteers.

Authors:  Jean-Paul Macher; Samuel Lévy
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 5.  Ivabradine in Cardiovascular Disease Management Revisited: a Review.

Authors:  Christopher Chen; Gurleen Kaur; Puja K Mehta; Doralisa Morrone; Lucas C Godoy; Sripal Bangalore; Mandeep S Sidhu
Journal:  Cardiovasc Drugs Ther       Date:  2021-01-07       Impact factor: 3.727

Review 6.  Hemodynamic effects of ivabradine use in combination with intravenous inotropic therapy in advanced heart failure.

Authors:  Mohammed Elzeneini; Juan M Aranda; Mohammad Al-Ani; Mustafa M Ahmed; Alex M Parker; Juan R Vilaro
Journal:  Heart Fail Rev       Date:  2020-09-30       Impact factor: 4.214

7.  New onset migraine with aura after treatment initiation with ivabradine.

Authors:  Till Sprenger; Weera Supronsinchai; Peter J Goadsby
Journal:  J Headache Pain       Date:  2013-05-29       Impact factor: 7.277

8.  Comparison of the efficacy and tolerability of ivabradine and ranolazine in patients of chronic stable angina pectoris.

Authors:  Aditi Chaturvedi; Yogendra Singh; Harish Chaturvedi; Vijay Thawani; Sakshi Singla; Deepak Parihar
Journal:  J Pharmacol Pharmacother       Date:  2013-01

9.  Ih current is necessary to maintain normal dopamine fluctuations and sleep consolidation in Drosophila.

Authors:  Alicia Gonzalo-Gomez; Enrique Turiegano; Yolanda León; Isabel Molina; Laura Torroja; Inmaculada Canal
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

10.  High-pass filtering of input signals by the Ih current in a non-spiking neuron, the retinal rod bipolar cell.

Authors:  Lorenzo Cangiano; Claudia Gargini; Luca Della Santina; Gian Carlo Demontis; Luigi Cervetto
Journal:  PLoS One       Date:  2007-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.